sever
acut
respiratori
syndrom
spread
rapidli
across
globe
caus
pandem
although
known
transmit
via
droplet
altern
mode
transmiss
remain
unknown
transmiss
infect
ocular
tissu
fluid
controversi
hypothes
nasolacrim
system
act
conduit
virus
travel
upper
respiratori
tract
eye
henc
ocular
tissu
fluid
may
repres
potenti
sourc
studi
attempt
determin
possibl
transmiss
tear
assess
presenc
viral
isol
quantit
reversetranscript
polymeras
chain
reaction
rtpcr
analysi
patient
monitor
clinic
via
routin
nasopharyng
swab
result
compar
tear
understand
pattern
viral
shed
seventeen
coronaviru
diseas
patient
recruit
prospect
studi
singapor
obtain
inform
consent
studi
carri
accord
tenet
declar
helsinki
ethic
approv
domain
specif
review
board
nation
healthcar
group
singapor
nasopharyng
swab
sampl
collect
routin
clinic
monitor
patient
condit
wherea
tear
sampl
collect
pure
research
purpos
day
tear
nasopharyng
swab
sampl
collect
time
sampl
deliv
differ
lab
process
patient
show
posit
result
rtpcr
nasopharyng
swab
sampl
clinic
diagnost
laboratori
nasopharyng
swab
sampl
collect
univers
viral
transport
media
rna
extract
carri
use
nuclisen
easymag
system
marci
letoil
franc
use
star
fortitud
kit
acceler
technolog
pte
ltd
singapor
republ
singapor
ml
elut
use
perform
rtpcr
analysi
accord
manufactur
instruct
limit
detect
estim
fewer
copi
rna
tear
sampl
senior
consult
ophthalmologist
ra
use
schirmer
test
strip
vari
time
point
day
initi
develop
symptom
caution
taken
prevent
contamin
sampl
schirmer
strip
tear
collect
method
valid
previous
studi
sampl
eye
obtain
analyz
separ
collect
strip
place
individu
falcon
tube
univers
viral
transport
media
sampl
deliv
research
laboratori
process
sampl
use
inocul
cell
american
type
cultur
collect
atcc
day
incub
cell
observ
presenc
cytopath
effect
total
rna
extract
sampl
use
ezna
total
rna
kit
omega
biotek
inc
norcross
ga
accord
manufactur
instruct
sampl
analyz
realtim
quantit
rtpcr
detect
describ
previous
clinic
data
includ
age
gender
symptom
nasopharyng
swab
result
collect
electron
health
record
correl
rtpcr
result
ocular
symptom
assess
includ
red
eye
tear
blur
vision
discharg
color
desatur
symptom
chosen
base
ocular
manifest
coronavirus
known
infect
human
anim
symptom
assess
includ
fever
cough
short
breath
rhinorrhea
sore
throat
patient
recruit
none
demonstr
ocular
symptom
howev
patient
develop
conjunctiv
inject
chemosi
stay
hospit
tabl
avail
wwwaaojournalorg
fourteen
patient
show
upper
respiratori
tract
symptom
present
includ
cough
rhinorrhea
sore
throat
total
sampl
obtain
studi
period
sampl
obtain
first
second
third
week
initi
symptom
respect
sampl
show
neg
result
viral
isol
rtpcr
tear
result
compar
nasopharyng
swab
sampl
result
shown
figur
cycl
threshold
valu
nasopharyng
swab
sampl
featur
studi
viral
shed
tear
compar
nasopharyng
swab
sampl
result
cours
infect
previou
studi
show
posit
rtpcr
result
patient
tear
isol
viru
unsuccess
studi
evid
found
shed
tear
cours
diseas
viral
load
detect
nasal
throat
swab
shown
elev
period
approxim
week
onset
symptom
studi
tear
sampl
time
point
cover
week
activ
infect
provid
good
represent
full
diseas
cours
tear
sampl
show
neg
result
even
nasopharyng
swab
sampl
continu
show
posit
result
furthermor
patient
symptom
upper
respiratori
tract
infect
demonstr
viral
shed
tear
suggest
hypothesi
lacrim
duct
viral
conduit
may
true
importantli
patient
show
ocular
symptom
diseas
cours
evid
could
found
tear
sampl
suggest
transmiss
tear
regardless
phase
infect
like
low
studi
sever
limit
first
sampl
analyz
differ
laboratori
use
differ
assay
nasopharyng
swab
sampl
use
clinic
set
monitor
diseas
progress
analyz
clinic
diagnost
laboratori
wherea
tear
sampl
analyz
research
laboratori
although
limit
detect
research
laboratori
assess
logist
limit
note
tear
sampl
incub
cell
day
obtain
rna
rtpcr
exist
sampl
cytopath
effect
would
observ
even
context
falseneg
rtpcr
result
observ
neither
cytopath
effect
posit
rtpcr
result
thu
likelihood
found
tear
sampl
remain
low
second
tear
sampl
rather
conjunctiv
tissu
pandem
set
patient
alreadi
emot
distraught
light
diagnosi
henc
conjunctiv
tissu
sampl
avoid
reduc
patient
distress
despit
believ
result
highlight
low
risk
ocular
transmiss
acut
infect
conjunctiv
cell
cell
die
viralmedi
lysi
result
immun
reaction
cell
death
releas
viral
materi
tear
still
detect
via
rtpcr
third
studi
small
sampl
size
logist
limit
outbreak
respons
patient
also
usual
seek
treatment
day
symptom
develop
make
sampl
earli
infect
difficult
final
patient
show
ocular
symptom
studi
studi
patient
ocular
symptom
difficult
studi
patient
show
conjunctiv
congest
result
studi
suggest
risk
transmiss
tear
low
howev
definit
mechanist
studi
requir
sever
acut
respiratori
syndrom
known
infect
cell
via
receptor
studi
requir
prove
definit
presenc
corneal
conjunctiv
cell
futur
studi
involv
patient
ocular
symptom
also
requir
final
futur
studi
consid
associ
serum
viral
load
viral
shed
tear
unfortun
blood
sampl
analyz
experi
part
routin
clinic
investig
manag
patient
human
subject
human
subject
includ
studi
human
ethic
committe
domain
specif
review
board
nation
healthcar
group
singapor
approv
studi
research
adher
tenet
declar
helsinki
particip
provid
inform
consent
anim
subject
includ
studi
